GR-IR cells were significantly decreased in the RA compared with the VEH group (P=0.006); this was again normalized by mifepristone (P=0.03 RA+MIF vs RA;Number 3h). negative opinions. In the hypothalamic paraventricular nucleus, improved CRH+and c-fos+cells were found while a negative R2+/ER+correlation was present between the quantity of RAR-+and GR+cells. This was paralleled by improved RAR- and decreased GR protein manifestation in the hypothalamus. Additionalin vitrostudies Rabbit Polyclonal to Akt (phospho-Tyr326) confirmed that RA abolished GR-mediated glucocorticoid-induced suppression of CRH manifestation, indicating a negative cross-talk between RAR- and GR signaling pathways. Finally, the above changes could be rapidly normalized by treatment with GR antagonist mifepristone. We conclude that in addition to the classic’ RAR–mediated transcriptional control of CRH manifestation, disturbances in GR bad opinions constitute a novel pathway that underlies RA-induced HPA axis hyperactivity. The quick normalization by mifepristone may be of potential medical desire for this respect. Keywords:all-transretinoic acid, corticotropin-releasing hormone, major depression, glucocorticoid receptor, hypothalamuspituitaryadrenal axis, mifepristone (RU38486) == Intro == The retinoid family comprises vitamin A, its metabolite 13-cis-retinoic acid (13-cis-RA) and all-transretinoic acid (RA). 13-cis-RA reaches bioactivity mostly via isomerization to RA, which has a high affinity for the nuclear receptor retinoic acid receptor (RAR).1Emerging evidence demonstrate that retinoids are essential for the developing2,3,4as well as adult brain.5,6,7Through dietary vitamin A consumption or treatment of severe acne with 13-cis-RA, excessive retinoid intake in human beings has been implicated in mood disorders like depression. Evidence are from abundant medical case reports uncovering the association between retinoid treatment and depressive symptoms.8,9,10,11Recently, abnormal endogenous retinoid signaling has also been found in the brain of depressed patients.12,13In the paraventricular nucleus (PVN) of patients with affective disorders, both the density of WAY 181187 RAR–immunoreactive (IR) neurons and the numbers of corticotropin-releasing hormone (CRH)RAR- double-stained neurons were found to be significantly increased.12Moreover, compromised RA and BDNF-TrkB signaling was found in the prefrontal cortex of feeling disorder individuals, which was supported by a reduced expression of the key elements of RA synthesis and rate of metabolism in the dorsolateral prefrontal cortex/anterior cingulate cortex of seniors depressed individuals.13 Hypothalamuspituitaryadrenal (HPA) axis hyperactivity is often seen in depressive individuals.14CRH plays a central part in controlling pressure response and regulating HPA axis activity.15Previously, we had shown that RAR- upregulatesCRHgene expression by its recruitment to the CRH promoter.12Chronic RA treatment further induces HPA axis hyperactivity and anxiety-related behavior.16These findings provided an essential underlying mechanism for the involvement of RA in the pathophysiology of depression. Fine-tuning the rules of HPA axis activity through glucocorticoid receptor (GR)-mediated bad feedback is essential for adaptation to stress.17,18The peripheral impairments in GR negative feedback and elevations in basal cortisol levels that are paralleled by a central overproduction of CRH and vasopressin are prominent features in neuropsychiatric disorders.19,20,21Stressful life events also increase the risk of developing depression, while depressed patients with an incompletely attenuated HPA axis after antidepressant therapy have a higher risk for any relapse.22,23,24,25,26Furthermore, direct intracerebroventricular (i.c.v.) injection of CRH induces several behavioral symptoms of major depression in rodents.27On the other hand, successful antidepressant or anti-glucocorticoid treatment WAY 181187 may facilitate feedback inhibition by targeting GR.28,29,30,31However, whether alterations in GR-mediated negative feedback are involved in the RA-induced HPA changes remains elusive. In WAY 181187 the present study, we investigated: (we) whether acute RA infusion alters plasma CORT levels through RAR- (ii) whether chronic RA administration modulates HPA axis activity and induces any depression-like behavior via alterations in GR bad feedback; (iii) possible effects of RA on GR-mediated glucocorticoid suppression of CRH expressionin vitro; and finally, (iv) whether these guidelines can be normalized by treatment with the GR antagonist mifepristone (RU38486). == Materials and methods == == Animals == All animal experiments and procedures were approved by the animal honest committee of University or college of Technology and Technology of China and in accordance with the guideline for care and use of laboratory animals of the National Institutes of Health. A total of 66 male adult SpragueDawley rats (810 weeks of age, 300350 g) were housed under controlled conditions of a 12/12-h light/dark cycle with a standard diet and waterad libitumand were handled daily for one week before experiments started. Twelve-hour light cycle in the animal space was from 0700 to 1900. Heat and humidity were kept constant (2022 C and 5055%, respectively). Details for the acute experiment study are provided inSupplementary Methods. For the chronic experiment, 36 rats were assigned either to a vehicle (VEH;n=12), RA (n=12), vehicle plus mifepristone (VEH+MIF;n=6) or a RA plus mifepristone group (RA+MIF;n=6). Among the 36 rats, 24 rats (n=6 for each treatment group) were utilized for plasma corticosterone (CORT) evaluation, behavioral checks and subsequent immunohistochemical study. The additional 12 rats (n=6 for each VEH and RA group) were used for western blot analysis of mind hypothalamic samples. == I.c.v. surgery == I.c.v. surgery was performed 7 days before drug administration. With standard.
